Manufacturer
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG
Contents
Tenecteplase
Indication
Thrombolytic treatment of acute MI. Treatment initiated as soon as possible after symptom onset.
Instruction
Patient ≥90 kg 50 mg (10,000 U), ≥80 to <90 kg 45 mg (9,000 U), ≥70 to <80 kg 40 mg (8,000 U), ≥60 to <70 kg 35 mg (7,000 U), <60 kg 30 mg (6,000 U). Given as a single IV bolus over 5-10 sec.
Drug interaction
Drugs that affect coagulation/alter platelet function.
Malaysia
